Last reviewed · How we verify

NCT04442685: SPHC

The Swiss Registry for Heart Diseases in Children Living in Switzerland. SPHC

Completed Last updated 1 February 2024
What this trial tests

trial in Heart Disease Congenital in 590 participants. Completed in 15 December 2023.

Timeline
1 June 2019
Primary endpoint
15 December 2023
15 December 2023

Quick facts

Lead sponsorUniversity Children's Hospital, Zurich
StatusCompleted
Study typeOBSERVATIONAL
Enrollment590
Start date1 June 2019
Primary completion15 December 2023
Estimated completion15 December 2023
Sites1 location across Switzerland

Conditions studied

Sponsor

University Children's Hospital, Zurich

Who can join

Adults 1 Day to 18, any sex, with Heart Disease Congenital. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Swiss Pediatric Heart Cohort aims to collect representative longitudinal data on all children diagnosed with a clinically relevant heart disease in Switzerland. The long-term goal is to optimize diagnosis and therapy, and to allow setting up national research projects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Heart Disease Congenital

Currently open trials in the same condition.

Other University Children's Hospital, Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04442685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing